Quarterly report pursuant to Section 13 or 15(d)

SHAREHOLDERS' DEFICIT - Stock Options (Details)

v3.24.3
SHAREHOLDERS' DEFICIT - Stock Options (Details) - Stock options - $ / shares
6 Months Ended 12 Months Ended
Jun. 30, 2024
Dec. 31, 2023
Dec. 31, 2022
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]      
Options at beginning of period (in shares) 2,024 2,724  
Options granted (in shares)   556  
Options expired (in shares) (298)    
Options canceled (in shares) (926) (1,256)  
Options at end of period (in shares) 800 2,024 2,724
Options vested and exercisable as at end of the period 791    
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]      
Exercise Price at beginning of period (in dollars per share) $ 1,683.90 $ 2,332.80  
Options granted (in dollars per share)   15.48  
Options expired (in dollars per share) 2,808.00    
Options canceled (in dollars per share) 717.98 2,354.76  
Exercise Price at end of period (in dollars per share) 2,156.27 $ 1,683.90 $ 2,332.80
Exercise Price vested and exercisable (in dollars per share) $ 2,149.81    
Share-based Compensation Arrangement by Share-based Payment Award, Options, Additional Disclosures [Abstract]      
Weighted Average Remaining Contractual Life (in years) 1 year 9 months 18 days 3 years 6 months 2 years 9 months 18 days
Weighted Average Remaining life vested and exercisable (in years) 1 year 9 months 18 days